JMPWA
RCKT icon

JP Morgan Private Wealth Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-36,530
Closed -$726K – 1774
2023
Q2 		$726K Buy
36,530
+1,411
+4% +$28.5K ﹤0.01% 882
2023
Q1 		$602K Sell
35,119
-1,619
-4% -$31.7K ﹤0.01% 1397
2022
Q4 		$719K Buy
+36,738
New +$677K ﹤0.01% 1306

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

JP Morgan Private Wealth Advisors's RCKT Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q3 2023, closing a stake of 36,530 shares — an estimated $726K sold.

JP Morgan Private Wealth Advisors first reported a position in RCKT in Q4 2022 and held it in 3 quarters. The position peaked at $726K in Q2 2023. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Rocket Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 36,530 Rocket Pharmaceuticals shares in Q3 2023, an estimated $726K.
  • JP Morgan Private Wealth Advisors first reported a position in Rocket Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's Rocket Pharmaceuticals position peaked at $726K in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.